These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clorazepate dipotassium, diazepam and placebo in chronic anxiety. Feurst SI Curr Ther Res Clin Exp; 1973 Jul; 15(7):449-59. PubMed ID: 4198306 [No Abstract] [Full Text] [Related]
3. [Comparative study of the anxiolytic efficacy of lorazepam (WY 4036) and diazepam (Valium)]. De Buck R; Boon H; Pelc I Acta Psychiatr Belg; 1972 Mar; 72(2):185-98. PubMed ID: 4560256 [No Abstract] [Full Text] [Related]
4. Chlorazepate dipotassium in the treatment of anxiety associated with chronic gastrointestinal disease. Kasich AM Curr Ther Res Clin Exp; 1973 Mar; 15(3):83-91. PubMed ID: 4196231 [No Abstract] [Full Text] [Related]
5. Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations. Kingstone E; Villeneuve A; Kossatz I Curr Ther Res Clin Exp; 1969 Mar; 11(3):106-14. PubMed ID: 4976238 [No Abstract] [Full Text] [Related]
6. Clinical and computerized EEG effects of U-31,920, a new anxiolytic. Itil TM; Akpinar S; Ozkut H; Balki N; Herrmann WM Curr Ther Res Clin Exp; 1974 Jun; 16(6):642-54. PubMed ID: 4211146 [No Abstract] [Full Text] [Related]
7. Treatment of hospitalized alcoholics with doxepin and diazepam. A controlled study. Butterworth AT; Watts RD Q J Stud Alcohol; 1971 Mar; 32(1):78-81. PubMed ID: 4925863 [No Abstract] [Full Text] [Related]
9. Controlled trial of dipotassium clorazepate ("Tranxene") in anxiety. Cooper AJ; Magnus RV; Rose M; Phanjoo A; Lancaster NP; Pollard P; Knowlson P Br J Psychiatry; 1973 Oct; 123(575):475-6. PubMed ID: 4584032 [No Abstract] [Full Text] [Related]
10. [Methods and problems of clinical psychopharmacology. Results of a double blind study with Medazepam and placebo in geriatirc psychiatry]. Bergener M; Undeutsch D Arzneimittelforschung; 1968 Dec; 18(12):1563-6. PubMed ID: 4887291 [No Abstract] [Full Text] [Related]
11. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts. Sugerman AA; Miksztal MW; Freymuth HW J Clin Pharmacol New Drugs; 1971; 11(5):383-7. PubMed ID: 4935717 [No Abstract] [Full Text] [Related]
12. The therapeutic effects of lorazepam in psychotic patients treated with haloperidol: a double-blind study. Guz I; Moraes R; Sartoretto JN Curr Ther Res Clin Exp; 1972 Dec; 14(12):767-74. PubMed ID: 4629815 [No Abstract] [Full Text] [Related]
13. Major or minor tranquilizers for relief of common symptoms of psychoneurosis? Krivda JF J Psychiatr Nurs Ment Health Serv; 1974; 12(4):28-33. PubMed ID: 4368887 [No Abstract] [Full Text] [Related]
15. [Dibenzepin in depression. A controlled clinical trial]. Vinar O; Taussigová D Act Nerv Super (Praha); 1967 Nov; 9(4):359-61. PubMed ID: 4889063 [No Abstract] [Full Text] [Related]
16. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study. Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069 [No Abstract] [Full Text] [Related]
17. Clinical evaluation of a possible catechol-O-methyl transferase inhibitor in endogenous depression. Angrist B; Park S; Urcuyo L; Roffman M; Gershon S Curr Ther Res Clin Exp; 1973 Mar; 15(3):127-32. PubMed ID: 4196229 [No Abstract] [Full Text] [Related]
18. [Clinical studies on Wy 4036 (lorazepam), a new tranquilizing agent]. Schrappe O Arzneimittelforschung; 1971 Jul; 21(7):1079-82. PubMed ID: 4935399 [No Abstract] [Full Text] [Related]
19. [Clinical effect of nitrazepam on psychoneurosis with insomnia]. Kaneko J; Takaishi N; Ida H; Abe H; Hosaka M Saishin Igaku; 1969 Oct; 24(10):2142-8. PubMed ID: 4900118 [No Abstract] [Full Text] [Related]
20. Measurement of drug effects in newly hospitalized depressives. Rockliff BW Dis Nerv Syst; 1971 Aug; 32(8):532-7. PubMed ID: 4937543 [No Abstract] [Full Text] [Related] [Next] [New Search]